Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1983 1
1984 2
1985 1
1987 2
1988 1
1989 1
1990 3
1991 5
1992 3
1993 3
1994 4
1995 2
1996 3
1997 2
1999 1
2000 2
2001 1
2003 1
2004 1
2008 1
2010 1
2012 3
2013 6
2014 3
2015 3
2016 3
2017 7
2018 7
2019 4
2020 6
2021 7
2022 15
2023 26
2024 27
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Takahashi N, Kim I, Etienne G, Andorsky D, Issa GC, Larson RA, Bombaci F, Kapoor S, McCulloch T, Malek K, Yau L, Ifrah S, Hoch M, Cortes JE, Hughes TP; ASC4FIRST Investigators. Hochhaus A, et al. N Engl J Med. 2024 Sep 12;391(10):885-898. doi: 10.1056/NEJMoa2400858. Epub 2024 May 31. N Engl J Med. 2024. PMID: 38820078 Clinical Trial.
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.
Ikoma Y, Nakamura N, Kaneda Y, Takamori H, Seki T, Hiramoto N, Kitagawa J, Kanda J, Fujita K, Morishita T, Ochi Y, Chiba S, Sasaki N, Ichii M, Imada K, Watanabe M, Hishizawa M, Miyahara Y, Maesako Y, Tanaka Y, Oka S, Tsuji M, Yoshihara S, Mitani K, Ueda Y, Kitano T, Watanabe M, Sezaki N, Kondo T, Kasahara S, Takaori-Kondo A, Kanemura N, Ogawa S, Nannya Y. Ikoma Y, et al. Among authors: hiramoto n. Leukemia. 2025 Jun;39(6):1362-1367. doi: 10.1038/s41375-025-02625-3. Epub 2025 Apr 21. Leukemia. 2025. PMID: 40259101 Free PMC article.
Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study.
Fujimoto A, Miyazaki K, Yakushijin K, Fujino T, Munakata W, Ejima Y, Maruyama D, Kubota N, Maeda T, Takizawa J, Hiramoto N, Takeuchi M, Sakai R, Fukuhara N, Taguchi S, Asano N, Yamaguchi M, Suzuki R. Fujimoto A, et al. Among authors: hiramoto n. Leukemia. 2025 Apr;39(4):909-916. doi: 10.1038/s41375-025-02527-4. Epub 2025 Feb 17. Leukemia. 2025. PMID: 39962328 Free PMC article.
An open-label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid-dependent/steroid-resistant chronic GVHD.
Inamoto Y, Kato K, Kawakita T, Onishi Y, Matsuoka KI, Shiratori S, Ikegame K, Hiramoto N, Toyosaki M, Katayama Y, Murayama S, Sasagawa Y, Maeda Y, Hatake K, Teshima T. Inamoto Y, et al. Among authors: hiramoto n. Am J Hematol. 2024 Oct;99(10):1917-1926. doi: 10.1002/ajh.27424. Epub 2024 Jun 27. Am J Hematol. 2024. PMID: 38934629 Free article. Clinical Trial.
Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10).
Okuda R, Ochi Y, Saiki R, Yamanaka T, Terao C, Yoshizato T, Nakagawa MM, Zhao L, Ohyashiki K, Hiramoto N, Sanada M, Handa H, Kasahara S, Miyazaki Y, Sezaki N, Shih LY, Kern W, Kanemura N, Kitano T, Imashuku S, Watanabe M, Creignou M, Chonabayashi K, Usuki K, Ishikawa T, Gotoh A, Atsuta Y, Shiraishi Y, Mitani K, Chiba S, Takaori-Kondo A, Miyano S, Kamatani Y, Haferlach T, Hellström-Lindberg E, Matsuda K, Yoshida Y, Makishima H, Nannya Y, Ogawa S. Okuda R, et al. Among authors: hiramoto n. Leukemia. 2025 Mar;39(3):760-764. doi: 10.1038/s41375-024-02494-2. Epub 2024 Dec 23. Leukemia. 2025. PMID: 39715854 Free PMC article. No abstract available.
Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia.
Moriguchi M, Nakamae H, Nishimoto M, Sugita J, Yanada M, Toubai T, Hasegawa Y, Hino M, Nishida T, Kurita N, Sawa M, Fukuda T, Jinguji A, Ota S, Matsuoka KI, Eto T, Hiramoto N, Ando T, Kawamura K, Kanda Y, Atsuta Y, Ohbiki M, Nakasone H, Konuma T. Moriguchi M, et al. Among authors: hiramoto n. Br J Haematol. 2024 Dec;205(6):2376-2386. doi: 10.1111/bjh.19825. Epub 2024 Oct 22. Br J Haematol. 2024. PMID: 39439234
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Nannya Y, Tobiasson M, Sato S, Bernard E, Ohtake S, Takeda J, Creignou M, Zhao L, Kusakabe M, Shibata Y, Nakamura N, Watanabe M, Hiramoto N, Shiozawa Y, Shiraishi Y, Tanaka H, Yoshida K, Kakiuchi N, Makishima H, Nakagawa M, Usuki K, Watanabe M, Imada K, Handa H, Taguchi M, Kiguchi T, Ohyashiki K, Ishikawa T, Takaori-Kondo A, Tsurumi H, Kasahara S, Chiba S, Naoe T, Miyano S, Papaemanuil E, Miyazaki Y, Hellström-Lindberg E, Ogawa S. Nannya Y, et al. Among authors: hiramoto n. Blood Adv. 2023 Jul 25;7(14):3624-3636. doi: 10.1182/bloodadvances.2022009564. Blood Adv. 2023. PMID: 36989067 Free PMC article.
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.
Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Fuji S, et al. Among authors: hiramoto n. Br J Haematol. 2024 Mar;204(3):959-966. doi: 10.1111/bjh.19228. Epub 2023 Nov 30. Br J Haematol. 2024. PMID: 38037468
161 results